– CANADA, Toronto – Vital Biosciences announced the appointment of Douglas Bryant to its Board as an Independent Director, bringing more than three decades of industry experience, undertaking multiple global leadership roles at companies like Abbott Laboratories Inc., Luminex Corporation, and most recently QuidelOrtho Corporation.
About
Mr. Bryant assumed the role of President and CEO of Quidel Corp. in March 2009. He led the company during the acquisition of Ortho Clinical Diagnostics and subsequent renaming to QuidelOrtho in May 2022. San Diego Business Journal named Mr. Bryant CEO of the Year in 2023.
“Enabling access to testing and care has been one of the guiding tenants in my career. VitalBio’s elegant platform represents an opportunity for me to contribute toward bringing a technological breakthrough in testing closer to patients,” said Douglas Bryant. “VitalBio is building a future where patients and healthcare providers can spot trends sooner, respond quicker, and chart the course ahead with accuracy and confidence. I’m excited to partner with Vasu and the excellent VitalBio team as they bring the VitalOne through FDA studies and to market.”
Mr. Bryant played a key role in the public health response to the COVID-19 outbreak. Under his leadership, Quidel brought to market the first global rapid antigen test, and rapidly scaled all aspects of research, production, and distribution to get tests in the field by May 8, 2020. During the pandemic, Bryant also led his team to increase test capacity by tenfold, from approximately 100 million per year to nearly 1 billion tests.
Before joining Quidel, Mr. Bryant served as EVP and COO at Luminex Corporation, managing its Bioscience Group, Luminex Molecular Diagnostics, manufacturing, R&D, technical operations, and commercial operations. From 1983 to 2007, he held various worldwide commercial operations positions with Abbott Laboratories.
About Vital Biosciences
Vital Biosciences is a team of scientists and engineers developing advanced diagnostic technologies. Our ecosystem of devices, software, and services aims to make healthcare radically more personalized, proactive, and accessible.
For more information: https://vitalbio.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
